“Regulatory FDA and EMA discussions are prioritised now”
In a US30 odd billion dollar cancer indication , of which
Immutep owns 100% of the trialed drug.
“Regulatory FDA and EMA discussions are prioritised now”In a...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.0¢ | 30.5¢ | $922.9K | 2.963M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 149460 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |